Medtech in Switzerland 2030

In order to permanently strengthen its position as one of the most attractive global medtech locations, Switzerland needs a joint strategy that includes all the players and stakeholders. Today in Bern, several hundred guests attended a presentation of Swiss Medtech’s vision for «Medtech in Switzerland 2030». The plan’s main objective is to continue the successful track record of the Swiss medical technology industry into the future.

Media release Order free copy of report

Swiss Medtech Award 2022: The finalists are confirmed

AlveoliX AG, Biospectal SA und Healios AG are advancing to the final of the coveted Swiss Medtech Award 2022. The three companies emerged victorious from a field of around twenty competitors. Thanks to the sponsors Lichtsteiner Foundation, Sonova Group, Straumann Group, and Ypsomed AG, the innovation prize worth 75,000 Swiss francs will be awarded for the fifth time this year. The winner of the prize money and trophy will be announced at Swiss Medtech Day on 14 June in Bern.
Press release Swiss Medtech Award

NEWS

18.05.22 News

Impressions from the General Meeting

Yesterday's Swiss Medtech General Meeting attracted around 400 people to Bern. The audience included association members, as well as guests from the fields of business, healthcare, the federal administration, politics, and the media.

17.05.22 Press release

Medtech in Switzerland 2030

Swiss Medtech outlines a way to permanently strengthen the industry

04.05.22 IVDR News

Publication of the IvDO

With just under a month to go before it comes into force, the Swiss authorities today adopted the new Regulation on In-vitro Diagnostics (IvDO), which is largely based on its European counterpart, the IVDR.

29.04.22 MDR News